The product of the cbl oncogene forms stable complexes in vivo with endogenous Crk in a tyrosine phosphorylation-dependent manner

Molecular and Cellular Biology

Volumn 16, Issue 1, 1996, Pages 45-52

  Ribon, Vered ^a,b   Hubbell, Susan ^b   Herrera, Roman ^b   Saltiel, Alan R ^a,b  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENE PRODUCT; ONCOPROTEIN;

ANIMAL CELL; ARTICLE; CELL STRAIN 3T3; CELL STRAIN K 562; FIBROBLAST CULTURE; LEUKEMIA CELL LINE; NONHUMAN; ONCOGENE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN PHOSPHORYLATION;

3T3 CELLS; ANIMAL; BINDING SITES; CELL LINE; FUSION PROTEINS, BCR-ABL; HUMAN; MICE; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENES; RETROVIRIDAE PROTEINS, ONCOGENIC; SRC HOMOLOGY DOMAINS; T-LYMPHOCYTES; TRANSFORMATION, GENETIC; TUMOR CELLS, CULTURED; TYROSINE;

EID: 0029655999     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.16.1.45     Document Type: Article

References (49)

1. Andoniou, C. E., C. B. F. Thien, and W. Y. Langdon. 1944. Tumour induction by activated abl involves tyrosine phosphorylation of the product of the cbl oncogene. EMBO J. 13:4515-4523.
2. Batzer, A. G., D. Rotin, J. M. Urena, E. Y. Skolnik, and J. Schlessinger. 1994. Hierarchy of binding sites for Grb2 and Shc on the epidermal growth factor receptor Mol Cell Biol 14:5112-5203.
3. Birge, R. B., E. J. Fajardo, C. Reichman, S. E. Shoelson, Z. Songyang, L. C. Cantley, and H. Hanafusa. 1993 Identification and characterization of a high-affinity interaction between v-Crk and tyrosine-phosphorylated paxillin in CT10-transformed fibroblasts. Mol Cell Biol. 13:4648-4656.
4. Blake, T., J. Heath, and W. Y. Langdon. 1993. The truncation that generated the v-cbl oncogene reveals an ability for nuclear transport. DNA binding and acute transformation. EMBO J 12:2017-2026.
5. Blake, T., J. Shapiro, H. Morse, and W. Y. Langdon. 1991 The sequences of the human and mouse c-cbl proto-oncogenes show v-cbl was generated by a large truncation encompassing a proline-rich domain and a leucine zipper-like motif. Oncogene 6:653-657.
6. Chan, L. C., K. K. Karhi, S. I. Rayter, N. Heistercamp, S. Eridani, R. Powels, S. D. Lawler, J. Groffen, J. G. Foulkes, M. F. Greaves, and L. M. Weidenmann. 1987. A novel abl protein expressed in Philadelphia chromosome positive acute lymphoblastic leukemia. Nature (London) 325:635-637.
7. Donovan, J. A., R. L. Wagne, W. Y. Langdon, and L. E. Samelson. 1994. The protein product of the c-cbl protooncogene is the 120-kDa tyrosine-phosphorytated protein in Jurkat cells activated via the T cell antigen receptor. J. Biol. Chem 269:22921-22924.
8. Feller, S. M., B. Knudsen, and H. Hanafusa. 1994 c-Abl kinase regulates the protein binding activity of c-Crk EMBO J. 13:2341-2351.
9. Feller, S. M., B. Knudsen, and H. Hanafusa. 1995 Cellular proteins binding to the first src homology 3 (SH3) domain of the proto-oncogene product c-Crk indicate Crk-specific signaling pathways Oncogene 10:1465-1473
10. Franz, W. M., P. Berger, and J. Y. Wang. 1989 Deletion of N-terminal regulatory domain of the c-abl tyrosine kinase activates its oncogenic potential. EMBO J 8:137-147.
11. Gale, N. W., S. Kaplan, E. J. Lowenstein, J. Schlessinger, and D. Bar-Sagi. 1993. Grb2 mediates the EGF-dependent activation of guanine nucleotide exchange on Ras. Nature (London) 363:88-92.
12. Galisteo, M. L., I. Dikie, A. G. Batzer, W. Y. Langdon, and J. Schlessinger. 1995. Tyrosine phosphorylation of the c-cbl proto-oncogene protein product and association with epidermal growth factor (EGF) receptor upon EGF stimulation. J. Biol. Chem. 270:20242-20245.
13. Hu, Q., D. Milfay, and L. T. Williams. 1995. Binding of NCK to SOS and activation of ras-dependent gene expression. Mol. Cell. Biol. 15:1169-1174.
14. Jackson, P., and D. Baltimore. 1989 N-terminal mutations activate the leukemogenic potential of the myristylated form of c-abl. EMBO J 8:449-456.
15. Knudsen, B., S. M. Feller, and H. Hanafusa. 1994. Four proline-rich sequences of the guanine-nucleotide exchange factor C3G bind with unique specificity to the first src homology 3 domain of crk J. Biol Chem. 269: 32781-32787
16. Kurzrock, R., M. Shtalrid, P. Romero, W. S. Kloetzer, M. Talpas, J. M. Trujillo, M. Blick, M. Beran, and J. U. Gutterman. 1987 A novel c-abl protein product in Philadelphia-positive acute lymphoblastic leukemia. Nature (London) 325:631-635.
17. Langdon, W. Y., J. W. Hartley, S. P. Klinken, S. K. Ruscetti, and H. C. Morse. 1989. v-cbl, an oncogene from a dual recombinant murine retrovirus that induces early B-lineage lymphomas. Proc. Natl. Acad. Sci. USA 91: 9665-9669.
18. Lazar, D. F., J. Jansen, M. Knez, E. Medof, P. Cuatrecasas, and A. R. Saltiel. 1994. Stimulation of glycogen synthesis by insulin in human erythroleukemia cells requires the synthesis of glycosyl-phosphatidylinositol. Proc. Natl Acad. Sci. USA 91:9665-9669.
19. Lowenstein, E. J., R. J. Daly, A. Batzer, W. Li, B. Margolis, R. Lammers, A. Ullrich, and J. Schlessinger. 1992 The SH2 and SH3 domain-containing protein GRB2 links receptor tyrosine kinases to ras signaling. Cell 70:431-442.
20. Lugo, T. G., A. M. Pendergast, A. J. Muller, and O. N. Witte. 1990. Tyrosine kinase activity and transformation potency of bcr-abl oncogene products. Science 247:1079-1082.
21. Matsuda, M., Y. Hashimuto, K. Muroya, H. Hasegawa, T. Kurata, S. Tanaka, S. Nakamura, and S. Hattori. 1994 CRK protein binds to two guanine nucleotide-releasing proteins for the ras family and modulates nerve growth factor-induced activation of ras in PC12 cells Mol Cell Biol 14: 5495-5500.
22. gagcrk, to a broad range of phosphotyrosine-containing proteins. Science 248:1537-1539.
23. Matsuda, M., B. J. Mayer, and H. Hanafusa. 1991. Identification of domains of the v-crk oncogene product sufficient for association with phosphotyrosine-containing proteins. Mol. Cell. Biol. 11:1607-1613.
24. Matsuda, M., S. Tanaka, S. Nagata, A. Kojima, T. Kurata, and M. Shibuya. 1992 Two species of human CRK cDNA encode proteins with distinct biological activities Mol Cell. Biol. 12:3482-3489.
25. Matuoka, K., M. Shibata, A. Yamakawa, and T. Takenawa. 1992. Cloning of ASH, a ubiquitous protein composed of one Src homology region (SH) 2 and two SH3 domains, from human and rat cDNA libraries Proc Natl Acad. Sci. USA 89:9015-9019.
26. Mayer, B. J., M. Hamaguchi, and H. Hanafusa. 1988. A novel viral oncogene with structural similarity to phospholipase C. Nature (London) 332:272-275.
27. Mayer, B. J., and H. Hanafusa. 1990. Mutagenic analysis of the v-crk oncogene: requirement for SH2 and SH3 domains and correlation between increased cellular phosphotyrosine and transformation J. Virol 64:3581-3589.
28. Mayer, B. J., H. Hirari, and R. Sakai. 1995 Evidence that SH2 domains promote processive phosphorylation by protein-tyrosine kinases. Curr. Biol 5:296-305.
29. McNamara, D. J., E. M. Dobrusin, G. Zhu, S. J. Decker, and A. R. Saltiel. 1993. Inhibition of binding of phospholipase Cγ1 SH2 domains to phosphorylated epidermal growth factor receptor by phosphorylated peptides. Int. J Pept Protein Res 42:240-248.
30. Meisner, H., B. R. Conway, O. Hartley, and M. P. Czech. 1995. Ineractions of Cb1 with Grb2 and phosphatidylinositol 3′-kinase in activated Jurkat cells. Mol Cell Biol 15:3571-3578.
31. Motto, D., S. Ross, J. Jackman, Q. Sun, A. Olson, P. R. Findell, and G. A. Koretzky. 1994. In vivo association of GRB2 with pp116, a substrate of the T cell antigen receptor-activated protein tyrosine kinase. J Biol. Chem. 269:21608-21613.
32. Muller, A. J., J. C. Young, A. M. Pendergast, M. Pondel, D. R. Littman, and O. N. Witte. 1991. BCR first exon sequences specifically activate the BCR/ ABL tyrosine kinase oncogene of Philadelphia chromosome-positive human leukemias. Mol Cell. Biol. 11:1785-1792.
33. Odai, H., K. Sasaki, A. Iwamatsu, Y. Hanazono, T. Tanaka, K. Mitani, Y. Yazaki, and H. Hirai. 1995 The proto-oncogene product c-Cbl becomes tyrosine phosphorylated by stimulation with GM-CSF or Epo and constitutively binds to the SH3 domain of Grh2/Ash in human hematopoietic cells. J. Biol. Chem. 270:10800-10805.
34. Pendergast, A. M., A. L. Quilliam, L. D. Cripe, C. H. Bassing, Z. Dai, N. Li, A. Batzer, K. M. Rabun, C. J. Der, J. Schlessinger, and M. L. Gishizky. 1993. BCR-ABL-induced oncogenesis is mediated by direct interaction with the SH2 domain of the GRB2 adaptor protein Cell 75:175-185.
35. Puil, L., J. Liu, G. Gish, G. Mbamalu, D. Bowtell, P. G. Pelicci, A. Arlinghanse, and T. Pawson. 1994 Bcr-Abl oncoproteins bind directly to activators of the Ras signaling pathway. EMBO J. 13:764-773.
36. Reichman, C. T., B. J. Mayer, S. Keshau, and H. Hanafusa. 1992. The product of the cellular crk gene consists primarily of SH2 and SH3 regions. Cell Growth Differ. 3:451-460.
37. Renshaw, M. W., J. R. McWhirter, and J. Y. J. Wang. 1995. The human leukemia oncogene bcr-abl abrogates the anchorage requirement but not the growth factor requirement for proliferation. Mol. Cell. Biol. 15:1286-1293.
38. Rivero-Lezcano, O., J. Sameshima, A. Marcilla, and K. Robbins. 1994. Physical association between src homology 3 elements and the protein product of the c-cbl proto-oncogene J Biol. Chem. 269:17363-17366.
39. Sakai, R., A. Iwamatsu, N. Hirano, S. Ogawa, T. Tanaka, H. Mano, Y. Yazaki, and H. Hirai. 1994. A novel signaling molecule. p130, forms stable complexes in vivo with v-Crk and v-Src in a tyrosine phosphorylation-dependent manner. EMBO J 13:3748-3756
40. BCR/ABL. J Biol. Chem. 270:5039-5047.
41. Sawasdikosol, S., K. S. Ravichandran, K. Kay Lee, J. Chang, and S. J. Burakoff. 1995 Crk interacts with tyrosine-phosphorylated p116 upon T cell activation. J. Biol. Chem. 270:2893-2896.
42. Schumacher, C., B. Knudsen, T. Ohuchl, P. Di Fiores, R. H. Glassman, and H. Hanafusa. 1995. The SH3 domain of Crk binds specifically to a conserved proline-rich motif in Eps15 and Eps15R. J. Biol Chem. 270:15341-15347.
43. Sieh, M., A. Batzer, S. Schlessinger, and A. Weiss. 1994. GRB2 and phosphohpase C-γ1 associate with a 36- to 38-kilodalton phosphotyrosine protein after T-cell receptor stimulation. Mol. Cell Biol 14:4435-4442.
44. Songyang, Z., S. E. Shoelson, M. Chaudhuri, G. Gish, T. Pawson, W. G. Haser, F. King, T. Roberts, S. Ratnofsky, R. J. Lechleider, B. G. Neel, R. B. Birge, J. E. Fajardo, M. Chou, H. Hanafusa, B. Schaffausen, and L. C. Cantley. 1993. SH2 domains recognize specific phosphopeptide sequences. Cell 72:767-778.
45. Tanaka, S., S. Hattori, T. Kurata, K. Nagashima, Y. Fukui, S. Nakamura, and M. Matsuda. 1993. Requirement of both the SH2 and SH3 domains for neuronal differentiation of PC12 cells induced by human CRK proteins. Mol. Cell. Biol. 13:4409-4415.
46. Tanaka, S., T. Morishita, Y. Hashimoto, S. Hattor, S. Nakamura, S. T. Takenawa, K. Matuoka, M. Shibuya, T. Kurata, K. Nagashima, and M. Matsuda. 1994. C3G, a guanine nucleotide releasing protein, binds to the SH3 domains of CRK and ASH/GRB2. Proc. Natl. Acad. Sci. USA 91:3443-3447.
47. Tanaka, S., L. Neff, R. Baron, and J. B. Levy. 1995. Tyrosine phosphorylation and translocation of the c-Cbl protein after activation of tyrosine kinase signaling pathways. J. Biol. Chem. 270:14347-14351
48. ten Hoeve, J., V. Kaartinen, T. Fiuretos, L. Haalaja, J. Voncken, N. Heisterkamp, and J. Groffen. 1994. Cellular interactions of CRKL, an SH2-SH3 adaptor protein. Cancer Res. 10:2563-2567.
49. ten Hoeve, J., C. Morris, N. Heisterkamp, and J. Groffen. 1993. Isolation and chromosomal localization of CRKL, a human CRK-like gene. Oncogene 8:2469-2474.